Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 238

    1.

    Visual hallucinations and Charles Bonnet syndrome after photodynamic therapy for age related macular degeneration.

    Cohen SY, Bulik A, Tadayoni R, Quentel G.

    Br J Ophthalmol. 2003 Aug;87(8):977-9.PMID: 12881339 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet syndrome).

    Abbott EJ, Connor GB, Artes PH, Abadi RV.

    Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1416-23.PMID: 17325191 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.

    Azab M, Benchaboune M, Blinder KJ, Bressler NM, Bressler SB, Gragoudas ES, Fish GE, Hao Y, Haynes L, Lim JI, Menchini U, Miller JW, Mones J, Potter MJ, Reaves A, Rosenfeld PJ, Strong A, Su XY, Slakter JS, Schmidt-Erfurth U, Sorenson JA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group; Verteporfin in Photodynamic Therapy (VIP) Study Group.

    Retina. 2004 Feb;24(1):1-12.PMID: 15076937 [PubMed - indexed for MEDLINE]Related articles

    4.

    Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.

    Voelker M, Gelisken F, Ziemssen F, Wachtlin J, Grisanti S.

    Graefes Arch Clin Exp Ophthalmol. 2005 Dec;243(12):1241-6. Epub 2005 Jul 12.PMID: 16010552 [PubMed - indexed for MEDLINE]Related articles

    5.

    One-year outcomes after photodynamic therapy in patients with age-related macular degeneration with poor baseline visual acuity.

    Potter MJ, Szabo SM.

    Graefes Arch Clin Exp Ophthalmol. 2006 Aug;244(8):1026-8. Epub 2005 Dec 8.PMID: 16341540 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Photodynamic therapy in age-related macular degeneration: one-year results]

    Ohira-Tochigi K, Yokoyama E, Matsumoto Y, Kyo T, Yuzawa M.

    Nippon Ganka Gakkai Zasshi. 2008 Oct;112(10):855-62. Japanese. PMID: 18949910 [PubMed - indexed for MEDLINE]Related articles

    7.

    Charles Bonnet syndrome in age-related macular degeneration: the nature and frequency of images in subjects with end-stage disease.

    Khan JC, Shahid H, Thurlby DA, Yates JR, Moore AT.

    Ophthalmic Epidemiol. 2008 May-Jun;15(3):202-8.PMID: 18569816 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

    Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1273-80. Epub 2007 Feb 28.PMID: 17333238 [PubMed - indexed for MEDLINE]Related articles

    9.

    Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.

    Spaide RF, Sorenson J, Maranan L.

    Ophthalmology. 2003 Aug;110(8):1517-25.PMID: 12917166 [PubMed - indexed for MEDLINE]Related articles

    10.

    Self-reported acute decrease in visual acuity after photodynamic therapy for age-related macular degeneration.

    Recchia FM, Greenbaum S, Recchia CA, Ruby AJ, Alldredge CD, Hassan TS.

    Retina. 2006 Nov-Dec;26(9):1042-8.PMID: 17151492 [PubMed - indexed for MEDLINE]Related articles

    11.

    Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.

    Chaudhary V, Mao A, Hooper PL, Sheidow TG.

    Ophthalmology. 2007 Dec;114(12):2183-9.PMID: 18054638 [PubMed - indexed for MEDLINE]Related articles

    12.

    Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital.

    Essex RW, Qureshi SH, Cain MS, Harper CA, Guymer RH.

    Clin Experiment Ophthalmol. 2003 Dec;31(6):476-81.PMID: 14641153 [PubMed - indexed for MEDLINE]Related articles

    13.

    Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration: results of an effectiveness study.

    Sharma S, Bakal J, Oliver-Fernandez A, Blair J.

    Arch Ophthalmol. 2004 Jun;122(6):853-6.PMID: 15197060 [PubMed - indexed for MEDLINE]Related articles

    14.

    Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).

    Gelisken F, Voelker M, Schwabe R, Besch D, Aisenbrey S, Szurman P, Grisanti S, Herzau V, Bartz-Schmidt KU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Aug;245(8):1085-95.PMID: 17219106 [PubMed - indexed for MEDLINE]Related articles

    15.

    Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.

    Sharp DM, Lai S, Markey CM.

    Clin Experiment Ophthalmol. 2007 Jan-Feb;35(1):24-31.PMID: 17300567 [PubMed - indexed for MEDLINE]Related articles

    16.

    Impact of lesion size on photodynamic therapy with verteporfin of predominantly classic lesions in age related macular degeneration.

    Arias L, Pujol O, Berniell J, Rubio M, Roca G, Castillo L, Acebes E.

    Br J Ophthalmol. 2005 Mar;89(3):312-5.PMID: 15722311 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Photodynamic therapy with verteporfin for choroidal neovascularisations in clinical routine outside the TAP study. One- and two-year results including juxtafoveal and extrafoveal CNV.

    Wachtlin J, Stroux A, Wehner A, Heimann H, Foerster MH.

    Graefes Arch Clin Exp Ophthalmol. 2005 May;243(5):438-45. Epub 2004 Dec 11.PMID: 15672299 [PubMed - indexed for MEDLINE]Related articles

    18.

    Verteporfin therapy in age-related macular degeneration (VAM): an open-label multicenter photodynamic therapy study of 4,435 patients.

    Bessler NM; Vam Study Writing Committee.

    Retina. 2004 Aug;24(4):512-20. Erratum in: Retina. 2004 Dec;24(6):990. PMID: 15300071 [PubMed - indexed for MEDLINE]Related articles

    19.

    A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration.

    Armbrecht AM, Aspinall PA, Dhillon B.

    Br J Ophthalmol. 2004 Oct;88(10):1270-3.PMID: 15377549 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Photodynamic therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration.

    Shyong MP, Lee FL, Chen SJ, Tung TH, Tsai DC, Hsu WM.

    J Chin Med Assoc. 2005 Sep;68(9):419-24.PMID: 16187598 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data